173 related articles for article (PubMed ID: 32581037)
1. Evaluation of New Monoclonal Anti-MyoD1 (MX049) for the Diagnosis of Rhabdomyosarcoma: Comparison with 5.8A, EP212, Anti-Desmin, Anti-Myogenin, and Fluorescence
He Y; Chen X; Yu X
Ann Clin Lab Sci; 2020 May; 50(3):412-416. PubMed ID: 32581037
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma.
Cui S; Hano H; Harada T; Takai S; Masui F; Ushigome S
Pathol Int; 1999 Jan; 49(1):62-8. PubMed ID: 10227726
[TBL] [Abstract][Full Text] [Related]
3. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to desmin identify the blastemal component of nephroblastoma.
Folpe AL; Patterson K; Gown AM
Mod Pathol; 1997 Sep; 10(9):895-900. PubMed ID: 9310952
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.
Morotti RA; Nicol KK; Parham DM; Teot LA; Moore J; Hayes J; Meyer W; Qualman SJ;
Am J Surg Pathol; 2006 Aug; 30(8):962-8. PubMed ID: 16861966
[TBL] [Abstract][Full Text] [Related]
6. Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression.
Wang NP; Bacchi CE; Jiang JJ; McNutt MA; Gown AM
Mod Pathol; 1996 May; 9(5):496-506. PubMed ID: 8733764
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma.
Tuohy JL; Byer BJ; Royer S; Keller C; Nagai-Singer MA; Regan DP; Seguin B
Vet Pathol; 2021 May; 58(3):516-526. PubMed ID: 33691532
[TBL] [Abstract][Full Text] [Related]
8. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.
Wang NP; Marx J; McNutt MA; Rutledge JC; Gown AM
Am J Pathol; 1995 Dec; 147(6):1799-810. PubMed ID: 7495304
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility.
Dias P; Parham DM; Shapiro DN; Tapscott SJ; Houghton PJ
Cancer Res; 1992 Dec; 52(23):6431-9. PubMed ID: 1384962
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
[TBL] [Abstract][Full Text] [Related]
11. Myogenin--a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1.
Michelagnoli MP; Burchill SA; Cullinane C; Selby PJ; Lewis IJ
Med Pediatr Oncol; 2003 Jan; 40(1):1-8. PubMed ID: 12426678
[TBL] [Abstract][Full Text] [Related]
12. MyoD1 and myogenin expression in human neoplasia: a review and update.
Folpe AL
Adv Anat Pathol; 2002 May; 9(3):198-203. PubMed ID: 11981115
[TBL] [Abstract][Full Text] [Related]
13. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
14. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
Rekhi B; Dodd L; Dharavath B; Dutt A
Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression.
Krskova L; Augustinakova A; Drahokoupilova E; Sumerauer D; Mudry P; Kodet R
Neoplasma; 2011; 58(5):415-23. PubMed ID: 21744995
[TBL] [Abstract][Full Text] [Related]
16. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases].
Yang L; Zhang HJ; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670
[No Abstract] [Full Text] [Related]
17. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas.
Wesche WA; Fletcher CD; Dias P; Houghton PJ; Parham DM
Am J Surg Pathol; 1995 Mar; 19(3):261-9. PubMed ID: 7872424
[TBL] [Abstract][Full Text] [Related]
18. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(4):427-34. PubMed ID: 16220232
[TBL] [Abstract][Full Text] [Related]
19. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(3):355-61. PubMed ID: 16010486
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: a Children's Oncology Group study.
Nicol K; Savell V; Moore J; Teot L; Spunt SL; Qualman S;
Pediatr Dev Pathol; 2007; 10(2):89-97. PubMed ID: 17378682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
